Bacterial Vaginosis
Bacterial vaginosis (BV) is the most common vaginal dysbiosis in women of reproductive age. Unlike genital infections caused by a single organism (such as gonorrhea, chlamydia or trichomoniasis), BV is not an inflammatory infection in which bacteria invade tissue; it is a profound ecological imbalance (dysbiosis) of the vaginal microbiome. Normally, Lactobacillus species (particularly L. crispatus and L. jensenii) dominate overwhelmingly (more than 90–95%), producing lactic acid to keep the environment protectively acidic (pH below 4.5) and H2O2 to suppress opportunistic microbes.
In dysbiosis, the Lactobacillus population collapses, allowing a polymicrobial anaerobic biofilm to take over, made up of Gardnerella vaginalis, Atopobium vaginae, Prevotella spp., Mobiluncus spp. and Mycoplasma hominis. Although BV does not cause a marked acute inflammatory reaction (the vagina is not bright red or swollen), it substantially increases the risk of acquiring sexually transmitted infections (HIV, HSV-2, chlamydia, gonorrhea, HPV) and is linked to pelvic inflammatory disease (PID), miscarriage, preterm birth and infection after gynecologic surgery.
Biofilm Pathogenesis and the Formation of Clue Cells
How the Polymicrobial Biofilm Starts
- Initiated by Gardnerella vaginalis: G. vaginalis adheres exceptionally well to vaginal epithelial cells and secretes vaginolysin, a toxin that punches holes in cell membranes. G. vaginalis then lays down a biofilm scaffold firmly attached to the mucosa.
- Recruitment of partner anaerobes: The biofilm creates a strictly anaerobic environment that attracts Atopobium vaginae, Prevotella and Mobiluncus. Atopobium vaginae is highly resistant to metronidazole when embedded in biofilm and is a major reason BV persists and recurs.
Sialidase Enzymes and the Appearance of Clue Cells
- Anaerobic bacteria produce sialidase and prolidase, enzymes that break down the protective mucus (mucin) layer of the vaginal lining.
- Clue cell formation: anaerobic rods and coccobacilli coat the entire surface of shed vaginal epithelial cells. Under the microscope, the cell borders are completely obscured and covered with bacteria, the most characteristic microscopic sign of BV.
- Fishy (amine) odor: Anaerobes convert amino acids into volatile amines such as putrescine, cadaverine and trimethylamine. In an alkaline setting (for example, on contact with semen or menstrual blood), these amines vaporize readily, releasing the typical fishy smell.
Amsel Criteria and the Nugent Score
Two standard systems are used to confirm BV clinically and in the laboratory:
Amsel Clinical Criteria
BV is diagnosed when at least 3 of the 4 criteria are met:
- Characteristic discharge: thin, uniform, grayish-white discharge that coats the vaginal walls evenly.
- Vaginal pH above 4.5: measured with dedicated pH paper using fluid from the lateral vaginal wall (avoiding cervical secretions or samples mixed with blood or semen).
- Positive whiff test: a strong fishy odor is released immediately when 1–2 drops of 10% KOH are added to a sample of discharge on a slide.
- Clue cells above 20%: clue cells make up more than 20% of epithelial cells on a saline (0.9% NaCl) wet mount or Gram stain.
Nugent Gram Stain Score (Research Gold Standard)
This score weighs the relative proportions of bacterial morphotypes under light microscopy (1000×):
- Lactobacillus morphotypes (large, long Gram-positive rods).
- Gardnerella / Bacteroides morphotypes (small Gram-negative or Gram-variable rods and coccobacilli).
- Mobiluncus morphotypes (curved Gram-negative rods).
- Score interpretation (0–10):
- 0–3 points: normal vaginal flora.
- 4–6 points: intermediate (mild or suspected dysbiosis).
- 7–10 points: confirms bacterial vaginosis (BV).
Differential Diagnosis of Vaginal Inflammation and Dysbiosis
| Bacterial vaginosis (BV) | Vaginal yeast infection (Candida albicans) | Trichomoniasis (Trichomonas vaginalis) |
|---|---|---|
| Anaerobic dysbiosis (biofilm) | Opportunistic fungal infection | Sexually transmitted infection (STI) |
| pH > 4.5 (always raised) | pH < 4.5 (normal) | pH > 4.5 (raised) |
| Thin, uniform, grayish-white discharge | Thick, clumpy, cottage cheese–like discharge | Frothy, thin, yellow-green discharge |
| Whiff test POSITIVE (fishy odor) | Whiff test negative | Whiff test usually negative (or faint) |
| No redness, no pain | Redness, intense itching, swelling | Redness, strawberry cervix |
| Clue cells > 20% | Yeast cells and pseudohyphae | Motile flagellated trichomonads |
How We Diagnose BV at Haute-Derma
Clinical Examination and Vaginal pH:
- A sterile speculum is used without preservative-containing lubricant.
- A dedicated pH strip (pH 3.6–6.1) is touched directly to the lateral vaginal wall for an accurate reading.
Wet Mount and Nugent Gram Stain in Our Lab:
- Saline (0.9% NaCl) wet mount: checks for clue cells and the proportion of neutrophils (in BV, the white cell to epithelial cell ratio is usually below 1:1), and rules out motile trichomonads.
- Whiff test: 10% KOH is added to check for amine release.
- Gram stain: used to calculate an accurate Nugent score.
Multiplex Real-Time PCR (for Recurrent Cases): This measures the DNA load of Gardnerella vaginalis, Atopobium vaginae and Megasphaera, along with the proportion of Lactobacillus strains, so that treatment can be tailored to the individual.
Treatment and Relapse Prevention at Haute-Derma
Standard First-Line Therapy (CDC Guidelines)
- Main oral regimen (preferred at Haute-Derma):
- Metronidazole: 500 mg by mouth twice daily for 7 consecutive days.
- Vaginal regimens (for pregnant women or those who cannot tolerate oral side effects):
- Metronidazole gel 0.75%: one applicator intravaginally at bedtime for 5 days.
- Clindamycin cream 2%: one applicator intravaginally at bedtime for 7 days.
- Alternative oral regimens:
- Tinidazole: 2 g by mouth once daily for 2 days, OR 1 g by mouth once daily for 5 days.
- Secnidazole: 2 g by mouth as a single dose (oral granules).
Managing Persistent, Recurrent BV
BV recurs in up to 30–50% of women within 3–6 months because the biofilm formed by Atopobium vaginae and G. vaginalis is not fully eradicated. Haute-Derma uses a three-step approach:
- Step 1 (clearance): metronidazole 500 mg by mouth twice daily for 7–14 days.
- Step 2 (biofilm disruption and maintenance): boric acid 600 mg vaginal suppositories nightly for 14 days to break up the anaerobic biofilm, followed by metronidazole gel 0.75% intravaginally twice a week for 3–6 months.
- Step 3 (restoring the ecosystem): vaginal and oral probiotics containing Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 to rebuild the natural protective layer.
